You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The University of Michigan spinout will use the funds to develop its InheRET platform, increase integration with EHRs, as well as increase its workforce and userbase.
Some of the firms will receive money to speed up test development, while others will use the funds to expand their testing and manufacturing capacity.
The award covers the first of five years for running and enhancing the All of Us Participant Technology Systems Center.
The grant, which was awarded under the NIH Pathway to Independence program, will fund research into the genetics of Alzheimer's disease.
The grant will allow Weill Cornell to study genetic, social, and clinical factors that might explain why COVID-19 disproportionally affects minorities in the US.
The sequencing firm said infectious disease research, diagnostics, screening, and surveillance could all increase demand for its NGS products.
In the next round of the eMERGE program, NIH is supporting development of methodologies for integrating genotypic and phenotypic risk scoring into clinical care.
The appropriations committee recommended that the NIH receive a total of $46.96 billion in NIH funding for FY 2021, a nearly 13 percent increase over its current budget.
Ten sites across the US will seek to integrate genomic risk assessment into clinical care, with a focus on diverse populations.
In December the firm won $4 million from CARB-X to support the platform's first test identifying the most common bloodstream infections associated with sepsis.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.